Conference call to discuss financial results
and recent business highlights to take place on Wednesday, August 28, 2024, at 8:00 AM ET
ROCKVILLE, Md., Aug. 14, 2024 /PRNewswire/ -- I-Mab (NASDAQ:
IMAB) (the "Company"), a US-based, global biotech company,
exclusively focused on the development of highly differentiated
immunotherapies for the treatment of cancer, today announced that
it plans to host a conference call and webcast on Wednesday, August 28, 2024, 8:00 AM ET to discuss financial results, pipeline
progress and recent business highlights for the half year ended
June 30, 2024.
I-Mab Conference Call and Webcast Information:
Investors and analysts are invited to join the conference call
at 8:00 AM ET on August 28, 2024, via:
- Domestic Dial-in: 1-877-407-0784
- International Dial-in: 1-201-689-8560
- Conference ID: 13747695
- Webcast: please click here
Note that Participants can use Guest dial-in #s above and be
answered by an operator OR click the Call me™ link for instant
telephone access to the event.
The Call me™ link will be made active 15 minutes prior to the
scheduled start time.
A webcast of the call will also be available on the I-Mab
website, on the Upcoming Events section of the
Investor Relations page, available by clicking here. A
replay of the call will be accessible under the Past
Events section of the Investor Relations page and
will be archived for 6 months.
About I-Mab
I-Mab (NASDAQ: IMAB) is a US-based, global
biotech company, exclusively focused on
the development of highly differentiated immunotherapies for
the treatment of cancer.
I-Mab has established operations in Rockville, Maryland. For more
information, please
visit https://www.i-mabbiopharma.com and follow us
on LinkedIn and X.
I-Mab Contacts
Investors &
Media
|
Tyler Ehler
|
Senior Director,
Investor Relations
|
IR@imabbio.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/i-mab-to-release-1h-2024-financial-results-on-august-28-2024-302221660.html
SOURCE I-Mab Biopharma